Tools4Patient presented data at the MDS Congress 2021 that predicted the placebo response in Parkinson’s disease (PD) in a multi-center, multi-national clinical study.
A representative from Tools4Patient discusses how grasping the ties between the two can help in reducing the impact of the placebo response in trials.
Tools4Patient is actively looking for a Junior/Senior Data Mining and Statistical Research Specialist. Look at our open position and stay tune.
Tools4Patient Proves Performance of Novel Technology to Predict Placebo Response in Osteoarthritis Clinical Trials
Belgian startup Tools4Patient recently presented data showing its novel technology Placebell©™ predicted placebo response in a Phase 2 randomized controlled trial (RCT) for osteoarthritis (OA). Placebell is the first robust technology using predictive modeling that is proven to reduce the impact of the placebo response in clinical trials under real-world conditions. Data from the Phase 2 RCT, “Predicting the Placebo Response in OA to Improve the Precision of the Treatment Effect Estimation,” was presented as a late-breaking abstract at the OARSI Connect Virtual World Congress on Osteoarthritis on April 29, 2021. This innovation by Tools4Patient is a major advancement for increasing clinical study success and reducing drug development costs and timelines.
US’s premier pain conference covering the field of pain research and therapeutics. Event Date: November 1 – 3,…
CNS Summit delivers programing, social events, networking, sponsorship opportunities and some of the fun – brought to you…
DTRA host the premier event uniting leading visionaries in decentralized research and clinical trials to share ideas, develop…
Sign up to join our regular newsletter.
Be the first to receive the latest innovations and news from Tools4Patient.